SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, a company committed to improving global health outcomes by empowering global communities with accessible cancer diagnostics, today announced that its OmniVerita™ system has been selected as the winner of CONNECT’s Most Innovative New Product Award in the Life Science Products, Clinical Stage category.
Read MoreSAN DIEGO--(BUSINESS WIRE)--Today, Biological Dynamics announced it has received a grant from the Bill & Melinda Gates Foundation to help address the pressing need of reducing the burden of tuberculosis (TB) in resource-poor settings.
Read MoreSAN DIEGO -Biological Dynamics, a company committed to improving global health outcomes by empowering global communities with accessible cancer diagnostics, today announced the appointment of Dr. Irwin M. Jacobs as Chairman of the Board. Dr. Jacobs is founding Chairman and CEO Emeritus of Qualcomm and Chairman Emeritus of the Salk Institute for Biological Studies.
Read MoreSan Diego, Calif. —April 13, 2018— Biological Dynamics, a company committed to improving global health outcomes by empowering global communities with low-cost, accessible cancer diagnostics, today announced two additions to its Board of Directors. Irwin Jacobs, founding Chairman and CEO Emeritus of Qualcomm and Chairman Emeritus of the Salk Institute for Biological Studies, and Martin J. Wygod, the founder of Medco Containment Services Inc. and former Chairman of WebMD Health Corp., have joined Biological Dynamics’ Board of Directors.
Read MoreBiological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.
